Clinical trials: Malignant Hepatobiliary Neoplasm
Malignant Hepatobiliary Neoplasm
Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions
This pilot phase II trial studies how well ponatinib hydrochloride works in treating patients with biliary cancer that has spread to other places in the body and that have alterations (fusions) in a gene known as fibroblast…
- Trial name
- NCT02265341
- Testing
- Laboratory Biomarker Analysis, Ponatinib Hydrochloride, Quality-of-Life Assessment
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Mayo Clinic